Treatment of disseminated renal cell cancer with combinations of interleukin-2, lymphokine-activated killer cells, and alpha-interferon.
作者信息
Stoter G, Goey S H, Batchelor D, Eggermont A M, Lamers C, Gratama J W, Bolhuis R L
机构信息
Department of Medical Oncology, Rotterdam Cancer Institute, Dr. Daniel den Hoed Kliniek, The Netherlands.
出版信息
Prog Clin Biol Res. 1992;378:225-33.
PMID:1301583
Abstract
摘要
Zotero 插件